Copyright
©The Author(s) 2004.
World J Gastroenterol. Sep 1, 2004; 10(17): 2472-2477
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2472
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2472
Table 1 Comparison of clinical and laboratory data, and tumor features between hepatocellular carcinoma (HCC) patients with and without thrombocytosis
HCC patients with thrombocytosis (n = 31) | HCC patients without thrombocytosis (n = 1123) | P value | |
Age (yr) | 52 ± 19 | 62 ± 12 | < 0.001 |
Sex (male: female) | 25:6 | 980:143 | 0.201 |
HBV: HCV: HBV + HCV-related | 24:1:0 | 711:179:49 | 0.114 |
Mean Child-Pugh’s scores | 7.2 ± 2.1 | 6.8 ± 2.2 | 0.336 |
Mean platelet counts (k/mm3) | 484 ± 87 | 154 ± 80 | < 0.001 |
Median (range) | 441 (403-688) | 133 (11-396) | |
Mean α-fetoprotein (ng/mL) | 251042 ± 458734 | 57879 ± 212788 | < 0.001 |
Median (range) | 4859 (4-1892500) | 252 (3-1621700) | |
Cirrhosis (+:-) | 23:8 | 913:210 | 0.445 |
MPV tumor thrombosis (+:-) | 11:20 | 171:952 | 0.005 |
Tumor metastases (+:-) | 10:21 | 196:927 | 0.059 |
Tumor volumes % | 63.5 ± 21.2 | 30.7 ± 26.9 | < 0.001 |
Both lobes with tumor involvements (+:-) | 22:9 | 439:684 | < 0.001 |
Therapy for HCC (+:-) | 10:21 | 583:540 | 0.048 |
Mean survival (d) | 144 ± 208 | 373 ± 521 | < 0.001 |
Median (range) | 77 (4-852) | 147 (2-3666) |
- Citation: Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY, Lee SD. Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(17): 2472-2477
- URL: https://www.wjgnet.com/1007-9327/full/v10/i17/2472.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i17.2472